The Rac-cGMP Signaling Pathway
Rac-cGMP 信号通路
基本信息
- 批准号:8208116
- 负责人:
- 金额:$ 33.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-01-01 至 2013-12-31
- 项目状态:已结题
- 来源:
- 关键词:ActinsAllosteric RegulationBiochemicalBlood VesselsCardiovascular DiseasesCardiovascular PhysiologyCatalytic DomainCyclic GMPCytoskeletal ModelingDevelopmentGuanosine Triphosphate PhosphohydrolasesGuanylate CyclaseHealthHumanIn VitroInvestigationLinkMediatingMembraneMolecularMonomeric GTP-Binding ProteinsPathway interactionsPhosphotransferasesPhysiologicalPhysiological ProcessesPlatelet-Derived Growth FactorProtein KinaseReceptor SignalingReportingResearchSecond Messenger SystemsSignal PathwaySignal TransductionSignaling MoleculeSystemVascular Endothelial Growth FactorsVascular Permeabilitiesatrial natriuretic factor receptor Acell motilityin vivomouse modelnovelp21 activated kinasepublic health relevancereceptorresponsesecond messenger
项目摘要
Project Description
The long-term objective of this project is to understand the signaling mechanisms
and physiological functions of the newly discovered Rac-cGMP pathway. Many
membrane-signaling receptors can increase the cellular levels of the ubiquitous
second messenger cyclic GMP (cGMP). However, the molecular mechanism by
which these membrane-signaling receptors increased cGMP was not known. We
recently uncovered a new Rac-cGMP signaling pathway. The small G protein
Rac uses its effector PAK (p21-activated kinase) to allosterically activate
transmembrane guanylyl cyclases (GCs). These findings reveal a general
mechanism for diverse signaling receptors to modulate physiological responses
through cGMP. Although the kinase activity of PAK is required, PAK does not
directly phosphorylate GCs. Instead, autophosphorylation of PAK is needed to
maintain its activated configuration. The active form of PAK then allosterically
activates transmembrane GCs. The main focus of this application is on the
biochemical mechanism by which Rac, through its effector PAK, regulates the
activity of transmembrane guanylyl cyclases. We will investigate the allosteric
activation of transmembrane guanylyl cyclases by PAK in the Specific Aim 1. In
the Specific Aim 2, we will explore the signaling molecules downstream of cGMP.
We will investigate the physiological function of the Rac-cGMP pathway in the
Specific Aim 3.
项目描述
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A new Rac/PAK/GC/cGMP signaling pathway.
- DOI:10.1007/s11010-009-0327-7
- 发表时间:2010-01
- 期刊:
- 影响因子:4.3
- 作者:Guo, Dagang;Zhang, J. Jillian;Huang, Xin-Yun
- 通讯作者:Huang, Xin-Yun
Stat3 is essential for neuronal differentiation through direct transcriptional regulation of the Sox6 gene.
- DOI:10.1016/j.febslet.2010.11.030
- 发表时间:2011-01-03
- 期刊:
- 影响因子:3.5
- 作者:Snyder M;Huang XY;Zhang JJ
- 通讯作者:Zhang JJ
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xin-Yun Huang其他文献
Xin-Yun Huang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xin-Yun Huang', 18)}}的其他基金
Molecular Basis of B1-Adrenergic Receptor Function
B1-肾上腺素受体功能的分子基础
- 批准号:
10414984 - 财政年份:2020
- 资助金额:
$ 33.96万 - 项目类别:
Molecular Basis of B1-Adrenergic Receptor Function
B1-肾上腺素受体功能的分子基础
- 批准号:
10034746 - 财政年份:2020
- 资助金额:
$ 33.96万 - 项目类别:
Molecular Basis of B1-Adrenergic Receptor Function
B1-肾上腺素受体功能的分子基础
- 批准号:
10618897 - 财政年份:2020
- 资助金额:
$ 33.96万 - 项目类别:
Molecular Basis of B1-Adrenergic Receptor Function
B1-肾上腺素受体功能的分子基础
- 批准号:
10224279 - 财政年份:2020
- 资助金额:
$ 33.96万 - 项目类别:
相似海外基金
Molecular insights into the allosteric regulation of opioid receptors
阿片受体变构调节的分子见解
- 批准号:
DE240100931 - 财政年份:2024
- 资助金额:
$ 33.96万 - 项目类别:
Discovery Early Career Researcher Award
Allosteric regulation of lysine degradation as a novel pathophysiological mechanism in glutaric aciduria type 1
赖氨酸降解的变构调节作为 1 型戊二酸尿症的一种新的病理生理机制
- 批准号:
10720740 - 财政年份:2023
- 资助金额:
$ 33.96万 - 项目类别:
Elucidating the Mechanism for Allosteric Regulation of SIRT1 through the N-terminal Region
阐明 SIRT1 通过 N 末端区域变构调节的机制
- 批准号:
10627735 - 财政年份:2023
- 资助金额:
$ 33.96万 - 项目类别:
Allosteric Regulation of Actin Capping Protein: Mechanism and Significance
肌动蛋白加帽蛋白的变构调节:机制和意义
- 批准号:
10330809 - 财政年份:2022
- 资助金额:
$ 33.96万 - 项目类别:
Allosteric Regulation of Actin Capping Protein: Mechanism and Significance
肌动蛋白加帽蛋白的变构调节:机制和意义
- 批准号:
10797746 - 财政年份:2022
- 资助金额:
$ 33.96万 - 项目类别:
Structural and functional studies of allosteric regulation of metabolic enzymes
代谢酶变构调节的结构和功能研究
- 批准号:
RGPIN-2020-04281 - 财政年份:2022
- 资助金额:
$ 33.96万 - 项目类别:
Discovery Grants Program - Individual
Allosteric Regulation of Actin Capping Protein: Mechanism and Significance
肌动蛋白加帽蛋白的变构调节:机制和意义
- 批准号:
10552651 - 财政年份:2022
- 资助金额:
$ 33.96万 - 项目类别:
Allosteric regulation of human cystathionine beta-synthase
人胱硫醚β-合酶的变构调节
- 批准号:
10602404 - 财政年份:2022
- 资助金额:
$ 33.96万 - 项目类别:
Allosteric regulation of human cystathionine beta-synthase
人胱硫醚β-合酶的变构调节
- 批准号:
10381000 - 财政年份:2022
- 资助金额:
$ 33.96万 - 项目类别:
Structural basis for allosteric regulation of RyR1
RyR1 变构调节的结构基础
- 批准号:
10366087 - 财政年份:2021
- 资助金额:
$ 33.96万 - 项目类别: